Lpl Financial LLC Oncolytics Biotech Inc Transaction History

Lpl Financial LLC

$320 Billion
Q3 2025

A detailed history of Lpl Financial LLC transactions in Oncolytics Biotech Inc stock. As of the latest transaction made, Lpl Financial LLC holds 51,355 shares of ONCY stock, worth $53,922. This represents 0.0% of its overall portfolio holdings.

Number of Shares

51,355

Holding current value

$53,922

% of portfolio

0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$0.75 - $1.43 $38,516 - $73,437	51,355 New	51,355 $71,000
Q1 2025 May 07, 2025	BUY	$0.55 - $0.93 $70 - $119	128 Added 0.8%	16,150 $8,000
Q4 2024 Feb 11, 2025	SELL	$0.74 - $1.4 $3,330 - $6,300	-4,500 Reduced 21.93%	16,022 $14,000
Q3 2024 Nov 08, 2024	BUY	$0.87 - $1.08 $11 - $14	13 Added 0.06%	20,522 $17,000
Q2 2024 Aug 07, 2024	BUY	$0.99 - $1.24 $2,475 - $3,100	2,500 Added 13.88%	20,509 $20,000

Q1 2024 May 10, 2024	SELL	$0.89 - $1.36 $1,397 - $2,135	-1,570 Reduced 8.02%	18,009 $19,000
Q4 2023 Feb 14, 2024	SELL	$1.22 - $2.09 $2,440 - $4,180	-2,000 Reduced 9.27%	19,579 $26,000
Q3 2023 Nov 13, 2023	BUY	$1.98 - $3.24 $42,726 - $69,915	21,579 New	21,579 $47,000
Q2 2022 Aug 12, 2022	SELL	$0.85 - $1.59 $4,250 - $7,950	-5,000 Reduced 23.24%	16,512 $17,000
Q1 2022 May 16, 2022	BUY	$1.31 - $2.02 $1,310 - $2,020	1,000 Added 4.88%	21,512 $34,000
Q4 2021 Feb 14, 2022	BUY	$1.39 - $2.3 $31 - $52	23 Added 0.11%	20,512 $29,000
Q3 2021 Nov 15, 2021	BUY	$1.93 - $2.77 $16,460 - $23,625	8,529 Added 71.31%	20,489 $43,000
Q2 2021 Aug 13, 2021	SELL	$2.6 - $4.64 $1,430 - $2,552	-550 Reduced 4.4%	11,960 $33,000
Q1 2021 May 14, 2021	BUY	$2.32 - $4.11 $2,320 - $4,110	1,000 Added 8.69%	12,510 $48,000
Q4 2020 Feb 12, 2021	SELL	$1.71 - $4.03 $3,420 - $8,060	-2,000 Reduced 14.8%	11,510 $27,000
Q2 2020 Aug 13, 2020	BUY	$1.33 - $2.76 $17,968 - $37,287	13,510 New	13,510 $25,000

Others Institutions Holding ONCY

# of Institutions

Shares Held

2.82M

Call Options Held

Put Options Held

View Full List

About ONCOLYTICS BIOTECH INC

Ticker ONCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,867,400
Market Cap $60.8M
Description
Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...

More about ONCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account